Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Link
http://link.springer.com/content/pdf/10.1186/1743-422X-9-18.pdf
Reference22 articles.
1. Williams R: Global challenges in liver disease. Hepatology. 2006, 44: 521-526. 10.1002/hep.21347.
2. World Health Organization Hepatitis C: 1999, [ http://www.who.int/immunization/topics/hepatitis_c/en/ ]
3. Cooreman MP, Schoondermark-Van de Ven EM: Hepatitis C virus. Biological and clinical consequences of genetic heterogeneity. Scand J Gastroenterol Suppl. 1996, 218: 106-115.
4. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998, 339: 1485-1492. 10.1056/NEJM199811193392101.
5. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo Gl: Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet. 1998, 352: 1426-1432. 10.1016/S0140-6736(98)07124-4.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment of Hepatitis C Post-Liver Transplantation Could Mitigate Discard Rates of Hepatitis C-Positive Deceased Donor Livers and Expand the Donor Pool;Journal of Transplantation;2021-01-25
2. Sofosbuvir and Ribavirin Combination Therapy Response in Various Hepatitis C Virus Genotypes in Peshawar, Khyber Pakhtunkhwa;Jundishapur Journal of Microbiology;2020-07-21
3. Spatial distribution of the trends in precipitation and precipitation extremes in the sub-Himalayan region of Pakistan;Theoretical and Applied Climatology;2019-01-18
4. Prevalence and Treatment of Untypable HCV Variants in Different Districts of Punjab, Pakistan;Viral Immunology;2018-07
5. END TREATMENT RESPONSE IN CHRONIC HEPATITIS C NAIVE PATIENTS BY STANDARD INTERFERON THERAPY IN RURAL AREA OF SINDH;INDO AM J PHARM SCI;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3